Investor revolt at Bayer to escalate after CEO keeps his job

Lower market value: Bayer logo sits on the exterior of the company’s pharmaceutical factory in Berlin. Bayer has lost 35 billion euros (US$39bil) in market value, due in large part to subsequent lawsuits that allege the main ingredient of Roundup – the weedkiller Bayer acquired through Monsanto – causes cancer. — Bloomberg

FRANKFURT: The shareholder rebellion at Bayer AG is poised to worsen after its supervisory board ignored an unprecedented no-confidence vote against the leadership of chief executive officer Werner Baumann.

Several top investors of the German chemicals and drugs giant are frustrated with directors’ decision to back Baumann and his strategy that led to the US$63bil takeover of Monsanto, according to people familiar with the matter.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Bayer , investor , revolt , CEO , job ,


Next In Business News

KWAP to invest RM500mil into newly launched Dana Perintis Fund
Tanco enters JV for residential development in Puchong Perdana
Bank of England halts run of interest rate hikes as economy slows
reNIKOLA unit enters subscription agreement for world's first climate sukuk
7-Eleven unit sells 75% stake in Caring Pharmacy to Big Pharmacy for RM675mil
Ringgit ends easier vs US$ after Fed's hawkish tone
Bursa Malaysia ends lower in sync with regional markets
AmBank continues to invest in SMEs towards growth, success
EcoWorld Malaysia on track to meeting FY23 target with sales of RM3.06bil
Google discussed dropping Broadcom as AI chips supplier

Others Also Read